Prediction of pathology and survival by FDG PET in gliomas

Journal of Neuro-Oncology

Volumn 64, Issue 3, 2003, Pages 227-237

  Padma, M Vasantha ^a   Said, S ^a   Jacobs, M ^a   Hwang, D R ^a   Dunigan, K ^a   Satter, M ^a   Christian, B ^a   Ruppert, J ^a   Bernstein, T ^a   Kraus, G ^a   Mantil, Joseph C ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Brain tumors; FDG PET; Gliomas

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHILD; DEATH; DRUG UPTAKE; FEMALE; GLIOMA; GRAY MATTER; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NONBIOLOGICAL MODEL; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSICIAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; WHITE MATTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; GLIOMA; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; STATISTICS; SURVIVAL RATE; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0141794250     PISSN: 0167594X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1025665820001     Document Type: Article

References (27)

1. Di Chiro G, DeLaPaz RL, Brooks RA: Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323-1329, 1982
2. Di Chiro G: Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors: A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371, 1986
3. Di Chiro G: Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest Radiol 22: 360-371, 1987
4. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T: Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33: 1972-1980, 1992
5. Janus TJ, Kim EE, Tilbury R, Bruner JM, Yung WK: Use of [18F] fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors. Ann Neurol 33: 540-548, 1993
6. Alavi JB, Alavi A, Chawluk J, Kushner M, Powe J, Hickey W, Reivich M: Positron emission tomography in patients with glioma. A predictor of prognosis. Cancer 62: 1074-1078, 1988
7. Patronas NJ, De Chiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816-822, 1985
8. Hamacher K, Coenen HH, Stoklin G: Efficient stereo-specific synthesis of no-carrier-added-2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. J Nucl Med 27: 235-238, 1986
9. Ding L, Goshtasby A, Satter M: Volume image registration by template matching. Image Vision Comput 19: 821-832, 2001
10. Evans AC, Marrett S, Collins L, Peters TM: Anatomical-functional correlative analysis of the human brain using three dimensional imaging systems. Proc. SPIE-MI III 1092: 264-274, 1989
11. Delbeke D, Meyerowitz C, Lapidus RL, Maciunas RJ, Jennings MT, Moots PL, Kessler RM: Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET. Radiology 195: 47-52, 1995
12. Roelcke U: PET: Brain tumor biochemistry. J Neuro-Oncol 22: 275-279, 1994
13. Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK: PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 69: 830-838, 1988
14. Herholz K, Piertrzyk U, Voges J, Schroder R, Halber M, Treuer H, Sturm V, Heiss WD: Correlation of glucose comsumption and tumor cell density in astrocytomas. J Neurosurg 79: 853-858, 1993
15. Fischman AJ, Alpert NM: FDG PET in oncology: There's more to it than looking at pictures. J Nucl Med 34: 6-11, 1993
16. Herholz K, Rudolf J, Heiss WD: FDG transport and phosphorylation in human gliomas measured with dynamic PET. J Neuro-Oncology 12: 159-165, 1992
17. De Witte O, Lefranc F, Levivier M, Salmon I, Brotchi J, Goldman S: FDG-PET as a prognostic factor in high-grade astrocytoma. J Neuro-Oncol 49: 157-163, 2001
18. Goldman S, Levivier M, Pirotte B, Brucher JM, Wikler D, Damhaut P, Dethy S, Brotchi J, Hilderbrand J: Regional glucose metabolism and histopathology of gliomas. A study based on positron emission tomography-guided stereotactic biopsy. Cancer 78: 1098-1106, 1996
19. Goldman S, Wikler D, Damhaut P, Monclus M, Levivier M, Pirotte B, De Witte O, Brotchi J, Hilderbrand J: Positron emission tomography and brain tumors. Acta Neurol Belg 97: 183-186, 1997
20. Meyer PT, Schreckenberger M, Petzger U, Meyer GF, Sabri O, Setani KS, Zeggel T, Buell U: Comparison of visual and ROI-based brain tumor grading using 18F-FDG PET: ROC analyses. Eur J Nucl Med 28: 165-174, 2001
21. Kim CK, Alavi JB, Alavi A, Reivich M: New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose. J Neuro-Oncol 10: 85-91, 1991
22. De Witte O, Levivier M, Violon P, Salmon I, Damhaut P, Wickler D, Hilderbrand J, Brotchi J, Goldman S: Prognostic value of positron emission tomography with FDG in low-grade glioma. Neurosurgery 39: 470-477, 1996
23. Muller W, Afra D, Schroder R: Supratentorial recurrences of gliomas: Morphological studies in relation to time intervals with astrocytomas. Acta Neurochir (Wein) 37: 75-91, 1977
24. Mineura K, Sasajima T, Kowada H, Ogawa T, Hatazawa J, Shishido F, Uemura K: Perfusion and metabolism in predicting the survival of patients with cerebral gliomas. Cancer 73: 2386-2394, 1994
25. Barker FG, Chang SM, Valk PE, Pounds TR, Prados MD: 18-Fluorodeoxyglucose uptake and survival of patients with suspected recurrent malignant glioma. Cancer 79: 115-126, 1997
26. Tyler JL, Diksic M, Villemure JG, Evans AC, Yamamoto YL, Feindel W: Metabolic and hemodynamic evaluation of gliomas using positron emission tomography. J Nucl Med 28: 1123-1133, 1987
27. Rozenthal JM, Cohen JD, Mehta MP, Levine RL, Hanson JM, Nickles RJ: Acute changes in glucose uptake after treatment: The effects of carmustine (BCNU) on human glioblastoma multiforme. J Neuro-Oncol 15: 57-66, 1993